Roka Bioscience
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$20.0m | Series C | ||
$47.5m | Series D | ||
N/A | $25.0m | Series E | |
N/A | $17.0m | Series E | |
N/A | N/A | IPO | |
N/A | $22.5m | Post IPO Equity | |
Total Funding | €99.5m |
Recent News about Roka Bioscience
EditRoka Bioscience specializes in developing rapid, highly accurate molecular assays and instrument systems for the Food Safety Industry. The company serves food manufacturers, laboratories, and food safety professionals, offering solutions that help mitigate risks, protect brands, and meet increasing testing demands. Operating in the food safety market, Roka Bioscience's business model revolves around selling its proprietary testing systems and consumables. The company generates revenue through the sale of these systems, as well as ongoing sales of assay kits and maintenance services. Established in 2009 as a spin-off from Hologic, Roka leverages advanced technologies such as Target Capture, Amplification, and Hybridization Protection Assay to deliver fully automated, single protocol assays. These technologies enable rapid pathogen detection with enhanced sensitivity and reduced enrichment times, providing significant workflow advantages and walk-away convenience for laboratories.
Keywords: molecular assays, food safety, pathogen detection, automation, laboratories, risk mitigation, brand protection, rapid testing, sensitivity, enrichment times.